NasdaqGS - Nasdaq Real Time Price USD

CEVA, Inc. (CEVA)

Compare
22.55
-3.66
(-13.96%)
At close: 4:00:02 PM EDT
22.55
+0.01
+(0.04%)
After hours: 4:00:33 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 29.22M
Earnings -1.74M

Q1'24

Q2'24

Q3'24

Q4'24

0
10M
20M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

21.00
37.17 Average
22.55 Current
45.00 High

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 5554
Avg. Estimate 0.070.10.530.91
Low Estimate 0.050.050.50.75
High Estimate 0.090.120.541.12
Year Ago EPS -0.050.170.360.53

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 4444
Avg. Estimate 26.55M27.7M116.28M129.68M
Low Estimate 26.5M26.7M115.2M123M
High Estimate 26.71M28.12M116.94M135M
Year Ago Sales 22.07M28.44M106.94M116.28M
Sales Growth (year/est) 20.29%-2.57%8.74%11.51%

Earnings History

Currency in USD 3/31/2024 6/30/2024 9/30/2024 12/31/2024
EPS Est. 0.030.030.10.11
EPS Actual -0.050.170.140.11
Difference -0.080.140.040
Surprise % -292.31%522.03%44.33%1.10%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate 0.070.10.530.91
7 Days Ago 0.080.110.550.81
30 Days Ago 0.080.110.550.81
60 Days Ago 0.080.110.550.98
90 Days Ago 0.080.110.550.98

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days 2--12
Up Last 30 Days 2--12
Down Last 7 Days 333--
Down Last 30 Days 333--

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
CEVA 240.80%-41.76%46.00%72.90%
S&P 500 6.69%6.80%9.98%14.34%

Upgrades & Downgrades

Maintains Rosenblatt: Buy to Buy 2/14/2025
Maintains Barclays: Overweight to Overweight 2/14/2025
Maintains Rosenblatt: Buy to Buy 2/11/2025
Maintains Northland Capital Markets: Outperform to Outperform 12/23/2024
Maintains Rosenblatt: Buy to Buy 11/8/2024
Maintains Roth MKM: Buy to Buy 11/8/2024

Related Tickers